Clinical Leader: Decentralization, it's more than you think

Decentralization will transform clinical research. Garri outlines its impact for his article on Clinical Leader.

Decentralized Clinical Trials (DCTs) enable remote participation in clinical research studies and democratize participant access. They eliminate the need for frequent in-person clinic visits, which can increase patient participation and accessibility. DCTs are particularly beneficial for diseases with small data pools, such as rare diseases.

DeSci, also known as decentralized science, calls for increased collaboration and transparency in scientific research. It leverages blockchain technology to achieve open and accessible research publications, community participation, and new streams of project funding.

Decentralization allows patients to be active participants in the research process and improve study outcomes. Blockchain technology is used to secure and anonymize patient data, empowering individuals to share their data more efficiently and giving them control over their data through dynamic consent.

The web3 community, associated with the decentralized movement for the internet, offers new fundraising options for clinical research. Vitalik Buterin's donations to research foundations set a precedent, and healthcare organizations have started accepting crypto donations and exploring NFT (Non-Fungible Token) collections for fundraising purposes.

Decentralization will make clinical trials more efficient, inclusive, and effective. Read the full article from Garri here.